TrialFrontiers in endocrinology2026
Dulaglutide versus empagliflozin as add-on therapy to metformin and sulfonylurea in type 2 diabetes: a randomized pilot study with exploratory metabolomic and microbiome analyses.
Ji Eun Jun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.